Board Member, Senior Managing Executive Officer, Vice President of Corporate Strategy Dept Kenzo Sawai PLAY LIST from the beginning Financial Results for the First Quarter of FY2017 (Apr. 1 to Jun. 30) Overview of the Financial Results for the 1Q of FY2017 Analysis of Factors Causing Changes in Operating Income Sales per Medical Institution Types (non-consolidated) Sales by Listed Year of Drugs Sales by Distribution Channels Comparison of Sales Volume FY2017 Earnings Forecasts(IFRS) FY2017 Earnings Forecasts(JGAAP) Member of the Board of USL Value Creation Vision for Sawai and USL Collaboration Consolidated Financial Highlights-1 Consolidated Financial Highlights-2 Consolidated Financial Date-1 Consolidated Financial Date-2 Disclaimer Back Next